Skip to main content
14 August 2026
21 January 2026

Syngene and Bristol Myers Squibb Broaden Integrated Drug Development Collaboration

Syngene International, a global contract research, development, and manufacturing organization, announced the extension of its long-standing strategic collaboration with Bristol Myers Squibb through 2035. The expanded agreement broadens the scope of integrated services across the drug development lifecycle spanning di…

21 January 2026

Insilico and Hygtia Collaborate on AI-Discovered NLRP3 Inhibitor for CNS Disorders

Insilico Medicine, a clinical-stage biotechnology company powered by generative artificial intelligence (AI), and Hygtia Therapeutics Co., Ltd., (Hygtia Therapeutics), announced a co-development collaboration agreement for Insilico's ISM8969 program. Through the partnership, the two parties aim to accelerate the globa…

16 January 2026

GCCL–OPIS Alliance Expands Integrated Clinical Trial Services

GCCL, a leading South Korea-based provider of clinical trial sample analysis, and OPIS, a global full-service contract research organization (CRO), have signed a Memorandum of Understanding (MOU) on the sidelines of the 44th Annual J.P. Morgan Healthcare Conference 2026 in San Francisco, USA, to expand their collabora…

16 January 2026

Zydus Completes Agenus Transaction, Enters Global Biologics CDMO Market

Zydus Lifesciences Limited is an innovation-led life-sciences company with an international presence, announced the successful closure of the Asset Purchase Agreement, Share Purchase Agreement, and the exclusive Licensing Agreement with Agenus Inc. This comprehensive closure follows the receipt of all the necessary re…

16 January 2026

Boston Scientific announces agreement to acquire Penumbra, Inc.

Boston Scientific Corporation and Penumbra, Inc., announced the companies have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in a cash and stock transaction that values Penumbra at $374 per share, reflecting an enterprise value of approximately $14.5 billion. "Penumbra is a w…

14 January 2026

Agentis Longevity Completes Acquisition of Arete Wellness

Under the ownership and leadership of CEO Jimmy St. Louis, Agentis Longevity has completed the acquisition of Arete Wellness, the performance-driven health platform founded by Adam Bobo and Van Hunt, uniting two leaders in longevity medicine and human optimization under a shared mission to help people live healthier, …

Rakuten Medical, LOTTE Biologics
14 January 2026

Rakuten Medical, LOTTE Biologics Sign Biopharma Manufacturing Agreement

Rakuten Medical, Inc. and LOTTE Biologics announced that they have signed a biopharmaceutical contract manufacturing agreement during the J.P. Morgan Healthcare Conference in San Francisco to strengthen Rakuten Medical's production capabilities for its innovative oncology therapy, Alluminox® platform-based photoimmuno…

13 January 2026

TetraScience and Thermo Fisher Collaborate to Advance Scientific AI in Biopharma

TetraScience, the Scientific Data and AI company, announced a collaboration with Thermo Fisher Scientific Inc., the world leader in serving science, with a goal of accelerating AI across biopharma R&D and manufacturing by transforming scientific data into AI-native form and developing intelligent workflows at scal…

12 January 2026

Nona Biosciences Expands Cell Therapy Pipeline Through Link Cell Therapies Alliance

Nona Biosciences ("Nona"), a global biotechnology company advancing biologics discovery through innovative technology platforms, announced that it has entered into a multi-target antibody discovery collaboration with Link Cell Therapies. This collaboration will leverage Nona's proprietary fully human HCAb Harbour Mice…

Page 19 of 37